Study Stopped
Study not started, investigators opted to focus on other projects.
Pre-Pilot: Problem Adaptation THerapy in Caregivers
PATH-Care
Pre-Pilot: Adapting and Testing an Evidence-Based Emotion Regulation Therapy for Use by Caregivers of Individuals With Alzheimer's Disease and Related Dementias (ADRD)
2 other identifiers
interventional
N/A
1 country
1
Brief Summary
The proposed pre-pilot project seeks to adapt an evidence-based psychosocial intervention-Pain Adaptation Therapy (PATH)-that employs emotion regulation, behavioral activation, and problem-solving skills training, that will be augmented with a caregiver (CG) education component, for use by CGs of individuals with Alzheimer's Disease and Related Dementias (ADRD).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2022
CompletedFirst Posted
Study publicly available on registry
October 5, 2022
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 31, 2025
January 1, 2025
11 months
September 30, 2022
January 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Change in Positive and Negative Affect as Measured by the Positive and Negative Affect Scale (PANAS)
The 20-item self-report Positive and Negative Affect Scale (PANAS-GEN) asks participants to describe to what extent they feel different feelings and emotions on average. Respondents answer on a five-point scale: 1=Very slightly or not at all, 2=A little, 3=Moderately, 4=Quite a bit, 5=Extremely. There are different subscales within this measure with 10 questions measuring positive affect, and 10 measuring negative affect. These have scores ranging from 10-50 with a higher score indicating higher positive affect, and a lower score indicating lower negative affect respectively.
At baseline; at week 10 (post-intervention)
Change in depression as measured by Montgomery-Asberg Depression Rating Scale (MADRS-S)
The 9-item self-report Montgomery-Asberg Depression Rating Scale asks participants about items like sadness, inner tension, sleep, and concentration. Respondents answer on a 7-point scale loosely by: 0=Normal, 2=Slight reduction, 4=Moderate reduction, and 6=Completely unable. These responses are personalized to the question a little more specifically. Scores range from 0-54 with a higher score indicating higher depression.
At baseline; at week 10 (post-intervention)
Change in caregiver burden as measured by Zarit Burden Interveiw (ZBI-12)
The 12-item self-report Zarit Burden Interview Scale asks participants "do you feel...?" with responses about caregiver burden like anger, stress, and social life. Respondents answer on a 5-point scale: 0= Never, 1=Rarely, 2=Sometimes, 3=Quite Frequently, 4=Nearly Always. Scores range from 0-48 with a higher score indicating higher burden.
At baseline; at week 10 (post-intervention)
Secondary Outcomes (6)
Change in efficacy and preparedness as measured by the Preparedness Caregiving Scale (PCS)
At baseline; at week 10 (post-intervention)
Change in emotion regulatory ability as measured by the Emotion Regulation Questionnaire (CERQ)
At baseline; at week 10 (post-intervention)
Change in positive aspects of caregiving as measured by the Positive Aspects of Caregiving scale (PAC)
At baseline; at week 10 (post-intervention)
Feasibility, Acceptability, and Usability of PATH-Care intervention
At week 10 (post-intervention)
Satisfaction as measured by Client Satisfaction Questionnaire (CSQ-3)
At week 10 (post-intervention)
- +1 more secondary outcomes
Study Arms (1)
PATH-Care
OTHERProblem Adaptation THerapy (PATH) adapted for caregivers along with tablet based exercises to enhance and reinforce the therapy sessions.
Interventions
Individuals will receive the 8-session PATH-Care intervention, delivered virtually (via videoconference or phone) to mitigate negative emotions and stress experienced by informal caregivers of individuals with ADRD. The therapist in the first session will also guide the participant in the tablet-based exercises (WELLPath).
Eligibility Criteria
You may qualify if:
- Age ≥ 18
- English speaking
- Informal caregiver of an individual with ADRD diagnosis
- Lives with or near the care recipient
- Provides at least 10 hours of care per week to a person with ADRD
- Has provided care to a person with ADRD for 6 months or more, prior to enrollment
- Cognitively intact (Score of ≥ 26 on adjusted MoCA-Blind)
- Score of ≥ 12 on the Negative Affect Scale of Positive and Negative Affect Schedule OR at least one significant negative emotion (score of ≥ 3)
You may not qualify if:
- Age ≤ 18
- Non-English speaking
- Paid caregiver
- Care recipient does not have ADRD diagnosis
- Provides care for less than 10 hours per week
- Has provided care for less than 6 months, prior to enrollment
- Care recipient is currently enrolled in hospice
- Meets criteria for severe Major Depression (Montgomery Asberg Depression Rating Scale ≥ 30) that may require hospitalization
- Significant Cognitive impairment (Score of \< 26 on adjusted MoCA-Blind)
- Score of \< 12 on the Negative Affect Scale of Positive and Negative Affect Schedule or no significant negative emotion
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Weill Medical College of Cornell Universitylead
- Cornell Universitycollaborator
Study Sites (1)
NewYork-Presbyterian - Weill Cornell Medicine
New York, New York, 10065, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cary Reid, MD PhD
Weill Medical College of Cornell University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2022
First Posted
October 5, 2022
Study Start
January 1, 2025
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
January 31, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share